CorMedix Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 CorMedix Inc 公司

CorMedix Inc. 是一家生物製藥公司。該公司專注於開發和商業化用於預防和治療危及生命的病症和疾病的治療產品。該公司專注於商業化其主打產品 DefenCath，這是一種抗菌導管鎖定溶液，經批准用於降低通過中央靜脈導管接受慢性血液透析的腎衰竭成年患者的導管相關血流感染髮生率。DefenCath 是一種由 13.5 mg/mL 牛磺羅定和 1000 USP 單位/mL 肝素組成的配方，用於降低通過中央靜脈導管 (CVC) 接受慢性血液透析的腎衰竭成年患者的導管相關血流感染 (CRBSI) 發生率。除了 DefenCath 之外，該公司還贊助了一項臨牀前研究合作，以研究牛磺羅定作爲罕見兒科腫瘤的潛在治療方法。

CorMedix Inc簡介



公司代碼CRMD

公司名稱CorMedix Inc

上市日期Mar 25, 2010

CEOMr. Joseph Todisco

員工數量64

證券類型Ordinary Share

年結日Mar 25

公司地址300 Connell Drive

城市BERKELEY HEIGHTS

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編07922

電話19085179500

網址https://cormedix.com/

公司代碼CRMD

上市日期Mar 25, 2010

CEOMr. Joseph Todisco

CorMedix Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Joseph Todisco

Chief Executive Officer, Director

302.20K

--

Mr. Steven W. Lefkowitz

Independent Director

127.65K

-3.77%

Ms. Susan Blum

Chief Financial Officer

69.69K

--

Ms. Janet M. Dillione

Independent Director

53.47K

-31.86%

Ms. Erin Mistry

Executive Vice President, Chief Commercial Officer

29.12K

-54.14%

Mr. Gregory Scott (Greg) Duncan

Independent Director

13.33K

--

Mr. Robert Stewart

Independent Director

11.00K

-69.44%

Mr. Dan Ferry

IR Contact Officer

--

Dr. Alan William Dunton, M.D.

Independent Director

--

Ms. Elizabeth (Liz) Massonhurlburt

Chief Operating Officer

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Joseph Todisco

Chief Executive Officer, Director

302.20K

--

Mr. Steven W. Lefkowitz

Independent Director

127.65K

-3.77%

Ms. Susan Blum

Chief Financial Officer

69.69K

--

Ms. Janet M. Dillione

Independent Director

53.47K

-31.86%

Ms. Erin Mistry

Executive Vice President, Chief Commercial Officer

29.12K

-54.14%

Mr. Gregory Scott (Greg) Duncan

Independent Director

13.33K

--

收入明細

FY2025Q2

FY2025Q1

FY2024

暫無數據

地區USD

名稱

營收

佔比

United States

39.74M

0.00%

業務

地區

暫無數據

股東統計

更新時間: 9月14日週日

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

6.42%

Abdalkader (Shaibatalhamd Aymen)

6.22%

The Vanguard Group, Inc.

5.77%

Marshall Wace LLP

3.46%

Citadel Advisors LLC

2.30%

其他

75.83%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

6.42%

Abdalkader (Shaibatalhamd Aymen)

6.22%

The Vanguard Group, Inc.

5.77%

Marshall Wace LLP

3.46%

Citadel Advisors LLC

2.30%

其他

75.83%

股東類型

持股股東

佔比

Investment Advisor

22.74%

Investment Advisor/Hedge Fund

13.43%

Hedge Fund

8.73%

Individual Investor

7.55%

Research Firm

1.48%

Pension Fund

0.63%

Bank and Trust

0.28%

Venture Capital

0.06%

Insurance Company

0.03%

其他

45.06%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

298

35.12M

47.05%

+4.14M

2025Q2

280

26.40M

35.51%

-7.69M

2025Q1

281

29.73M

44.27%

-179.25K

2024Q4

252

24.74M

40.82%

-30.08K

2024Q3

228

19.79M

34.25%

-1.78M

2024Q2

217

17.74M

32.28%

-4.09M

2024Q1

218

17.92M

32.60%

-5.73M

2023Q4

217

19.38M

35.35%

-2.82M

2023Q3

208

18.46M

33.68%

-3.54M

2023Q2

197

19.74M

38.10%

+6.18M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

4.80M

6.42%

+485.88K

+11.27%

Jun 30, 2025

Abdalkader (Shaibatalhamd Aymen)

4.65M

6.22%

+4.65M

--

Aug 08, 2025

The Vanguard Group, Inc.

4.31M

5.77%

+675.49K

+18.59%

Jun 30, 2025

Marshall Wace LLP

2.58M

3.46%

+2.35M

+1019.17%

Jun 30, 2025

Citadel Advisors LLC

1.71M

2.3%

+1.61M

+1517.64%

Jun 30, 2025

State Street Investment Management (US)

1.60M

2.15%

+62.52K

+4.06%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.60M

2.14%

+163.40K

+11.40%

Jun 30, 2025

Nuveen LLC

1.45M

1.94%

+1.27M

+740.45%

Jun 30, 2025

Alyeska Investment Group, L.P.

750.00K

1%

+750.00K

--

Jun 30, 2025

Ghisallo Capital Management LLC

750.00K

1%

+750.00K

--

Jun 30, 2025

持股ETF



更新時間: 10月6日週一

機構名稱

佔比

Invesco Dorsey Wright Healthcare Momentum ETF

2.14%

SPDR S&P Pharmaceuticals ETF

1.45%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

1.05%

First Trust Active Factor Small Cap ETF

0.44%

Janus Henderson Small Cap Growth Alpha ETF

0.32%

iShares Micro-Cap ETF

0.2%

Vanguard US Multifactor ETF

0.16%

Vanguard US Momentum Factor ETF

0.13%

Principal U.S. Small-Cap ETF

0.12%

Fidelity Small-Mid Multifactor ETF

0.12%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比2.14%

SPDR S&P Pharmaceuticals ETF

佔比1.45%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

佔比1.05%

First Trust Active Factor Small Cap ETF

佔比0.44%

Janus Henderson Small Cap Growth Alpha ETF

佔比0.32%

iShares Micro-Cap ETF

佔比0.2%

Vanguard US Multifactor ETF

佔比0.16%

Vanguard US Momentum Factor ETF

佔比0.13%

Principal U.S. Small-Cap ETF

佔比0.12%

Fidelity Small-Mid Multifactor ETF

佔比0.12%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據